Skip to main content
. 2022 Mar 2;13:100111. doi: 10.1016/j.ahjo.2022.100111

Table 4.

Secondary outcomes by H2FPEF score group.

Low score Intermediate score* High score p-Value
n 40 72 44
During initial admission
In-hospital mortality (%) 3 (7.5) 7 (9.7) 8 (18.2) 0.250
ICU level of care (%) 10 (25.0) 24 (33.3) 22 (50.0) 0.048
Mechanical ventilation (%) 5 (12.5) 11 (15.3) 5 (11.4) 0.818
Length of stay (median (IQR)) 4.00 [2.00, 10.00] 6.00 [3.00, 10.00] 7.50 [3.75, 15.25] 0.118
60-day outcomes
Readmission (%) 7 (17.5) 21 (29.2) 17 (38.6) 0.102
Life-threatening arrhythmia (%) 2 (5.0) 5 (6.9) 3 (6.8) 0.914
DVT (%) 0 (0.0) 2 (2.8) 2 (4.5) 0.415
HF exacerbation (%) 0 (0.0) 1 (1.4) 5 (11.4) 0.009
Requiring RRT (%) 2 (5.0) 5 (6.9) 4 (9.1) 0.764
PE (%) 1 (2.5) 2 (2.8) 1 (2.3) 0.986
Total MACE (%) 2 (5.0) 5 (6.9) 6 (13.6) 0.304
 Myocardial injury (%) 1 (2.5) 4 (5.6) 4 (9.1) 0.431
 Stroke (%) 0 (0.0) 0 (0.0) 1 (2.3) 0.278
 Cardiovascular death (%) 1 (2.5) 2 (2.8) 2 (4.5) 0.835

ICU = intensive care unit; IQR = interquartile range; MACE = Major adverse cardiac events; HF = heart failure; RRT = renal replacement therapy.

Low, intermediate, and high score groups defined as H2FPEF scores from 0 to 2, 3–5, and 6–9, respectively.

Defined as having the signs and symptoms consistent with a heart failure exacerbation.

Myocardial injury defined as cardiac troponin greater than the upper limit of normal.